Search - tctmd.com

Displaying 221 - 240 of 531

Sort: Relevancy | Date

News Daily News

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Yael L. Maxwell

September 17, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Shelley Wood

April 28, 2018

News Daily News

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Yael L. Maxwell

April 02, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

News Conference News ACC 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Shelley Wood

March 10, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

Advertisement

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Ticagrelor: Better Platelet Blockade Post-TAVR?

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content